UAB Looking For A Variety Of Patients For COVID-19 Clinical Trials
Infectious disease doctors at UAB said Tuesday they’re still looking for COVID-19 patients to join a number of clinical trials.
Currently, UAB is offering both inpatient and outpatient trials ranging from vaccines to treatments aimed at lessening the effects of the virus.
Dr. Sonya Heath, a professor of medicine in UAB’s Division of Infectious Diseases, said some of the outpatient trials could appeal to patients because they only require a single dose, four in-person visits and virtual check-ins.
One of the trials currently accepting patients involves convalescent plasma treatments, which take antibodies from recovered patients and injects them into patients who have COVID or those who have come into close contact with the virus.
“We are really asking the question: If you give high concentrations of antibody, is that beneficial in decreasing the severity of the illness and decreasing the likelihood that somebody will be hospitalized,” Heath said.
Other studies have shown that patients do better if their bodies generate an immune response to the virus.
“They have a shorter course of illness and their viral load is lower,” Heath said. “We know that generating an immune response is a good thing and decreases your symptoms and severity. Each of these studies … is looking at ways to transfer an immune response to you in some form or fashion.”
Dr. Turner Overton, from UAB’s outpatient COVID-19 clinic, says patients should enroll in clinical trials because it gives them a more heightened level of clinical care.
“We’re gaining knowledge and we have expertise here at UAB,” Overton said. “But if people sit at home and wait until they’re really sick, in the second week of illness, you know, the complications are much higher.”
UAB is looking for COVID-19 patients with varying degrees of symptoms.
Editor’s Note: UAB holds WBHM’s broadcast license but our news and business departments operate independently.
George Foreman, the fearsome heavyweight who became a beloved champion, dies at 76
The heavyweight who lost the "Rumble in the Jungle" to Muhammad Ali before authoring an inspiring second act as a 45-year-old champion and a successful businessman was 76.
Voice of America staff sue Trump administration for shutting down network
Six Voice of America journalists and a director at its parent agency have sued the Trump administration, alleging its moves to shut down the U.S.-funded network are unconstitutional.
Homeland Security makes cuts to civil rights and immigration oversight offices
DHS confirms it is implementing a reduction in force in three oversight offices as part of the effort to cut the federal workforce.
What’s the ideal age to reach a life milestone? Many Americans say it depends
Owning a home, starting a family or retiring: If these are things you want, what's the best age to do them? The Pew Research Center surveyed 3,600 U.S. adults to find out.
What we know about the case of detained Georgetown professor Badar Khan Suri
The Indian national and postdoctoral fellow is the latest scholar detained or deported by the Trump administration for speaking in support of Palestinian rights or criticizing Israel's actions in Gaza.
Screens and sleep. Maybe not so bad?
We hear a lot about how screens impact our sleep, but how significant is the disruption? And how much does exercise predict sleep quality? This story first appeared in the Body Electric newsletter.
